Completed NA INTERVENTIONAL 3-arm NCT06158659

Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula

Improved Immunology Outcomes Associated With Feihe Lactoferrin Fortified With HMO in Infant Formula: A Randomized, Controlled Trial

Sponsor: Heilongjiang Feihe Dairy Co. Ltd.

Conditions Cold Flu

Interventions Breastfeeding Control Formula Feihe Investigational Formula

Updated 5 times since 2024 Last updated: Dec 2, 2025 Started: Nov 14, 2023 Primary completion: Apr 3, 2025 Completion: Apr 3, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cold and Flu, this trial is completed. The trial is conducted by Heilongjiang Feihe Dairy Co. Ltd. and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2024 — Jan 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2024 — Jul 2024 [monthly]

Recruiting NA
Jan 2024 — Feb 2024 [monthly]

Recruiting NA

First recorded

Nov 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heilongjiang Feihe Dairy Co. Ltd.

Data source: Heilongjiang Feihe Dairy Co. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jinhua, China